Peptipedia
Library
MetabolicElevated cautionApproved molecule

Semaglutide

Ozempic · Wegovy · Rybelsus

A weekly GLP-1. Brand names exist as medicines. This catalog is educational, not a prescription.

A long-acting GLP-1 analog approved for type 2 diabetes and chronic weight management. Compounded versions circulate widely; they are not the branded pens and carry quality variability.

Usual range

0.25–2.4 mg

Schedule

Once weekly

Half-life

~7 days

How it is used

GLP-1 receptor agonist. Titrate slowly; branded ≠ compounded.

Subcutaneous · also Oral

Same day each week, any time. Abdomen, thigh, or upper arm rotation.

Indefinite while indicated, with medical supervision. Do not jump to the top dose.

How to mix this vial

Typical vial 2 mg · 2 mL BAC

2 mg + 2 mL → 1 mg/mL. 0.25 mg = 25 units. Many starter vials are 2–5 mg. Match math to the actual label.

Branded pens: follow label. Compounded: fridge, protect from heat.

Side effects

  • Nausea
  • Constipation or diarrhea
  • Fatigue
  • Gallbladder issues
  • Rare pancreatitis
  • Lean-mass loss if protein is low

Who should skip this

  • Personal/family history of medullary thyroid carcinoma or MEN2
  • Pregnancy
  • History of pancreatitis (relative)
  • Low BMI without indication

Nutrition note

Small protein-first meals. Low fat and low spice while titrating. Target ≥1.6 g/kg protein to protect muscle. Fluids and fiber for constipation.

Stacks

Often paired with

Approved drug. Peptipedia shows research/compounded reconstitution math for education — it is not a substitute for a prescribed pen.

Peptipedia is an educational calculator, not medical advice. Many catalog entries are unapproved for human use. Approved molecules have labels that outrank this app. Do not use this to self-prescribe. Consult a licensed clinician. Not for anyone under 18, pregnant, or being treated for cancer.